Feijie Zhang

3.2k citations

33 papers · 2.2k indexed · 1 hit paper · h-index 22

Co-authors: Mark A. Kay Shuo Gu Lan Jin Peter SarnowYong HuangYue ZhangKirk Chu Jianpeng Xu
Topics: Virus-based gene therapy research (12 papers)RNA Interference and Gene Delivery (12 papers)CRISPR and Genetic Engineering (11 papers)
Cited by: Cancer Research Molecular Biology Genetics
Journals: Nature Cell Proceedings of the National Academy of Sciences
Partner nations: United States China Japan

In The Last Decade

Feijie Zhang

31 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A transfer-RNA-derived small RNA regulates ribosome biogenesis

2017 405 citations Hak Kyun Kim, Gabriele Fuchs et al. Nature profile →

Peers

Countries citing papers authored by Feijie Zhang

Since Specialization

Citations

This map shows the geographic impact of Feijie Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feijie Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feijie Zhang more than expected).

Fields of papers citing papers by Feijie Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feijie Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feijie Zhang. The network helps show where Feijie Zhang may publish in the future.

Co-authorship network of co-authors of Feijie Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Feijie Zhang. A scholar is included among the top collaborators of Feijie Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feijie Zhang. Feijie Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stereo-random oligonucleotides enable efficient recruitment of ADAR in vitro and in vivo 2025 ·Nature Communications ·(unknown),(unknown),Paul Vogel,Inga Jarmoskaite,Jonathan M. Geisinger,(unknown),Marco Herrera‐Barrera,Feijie Zhang,Lisa Groß,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Mark A. Kay,Jin Billy Li,Thorsten Stafforst	0
2	AAV-mediated genome editing is influenced by the formation of R-loops 2024 ·Molecular Therapy ·Francesco Puzzo,Magdalena P. Crossley,(unknown),Feijie Zhang,Katja Pekrun,(unknown),Karlene A. Cimprich,Mark A. Kay	0
3	The AAV capsid can influence the epigenetic marking of rAAV delivered episomal genomes in a species dependent manner 2023 ·Nature Communications ·Adriana Gonzalez‐Sandoval,Katja Pekrun,(unknown),Feijie Zhang,King L. Hung,Howard Y. Chang,Mark A. Kay	31
4	Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transfer 2023 ·Molecular Therapy — Nucleic Acids ·Francesco Puzzo,Chuanling Zhang,Bethany Powell Gray,Feijie Zhang,Bruce A. Sullenger,Mark A. Kay	21
5	Fludarabine increases nuclease-free AAV- and CRISPR/Cas9-mediated homologous recombination in mice 2022 ·Nature Biotechnology ·(unknown),(unknown),Giulia Bortolussi,Feijie Zhang,Gabriele Baj,(unknown),Gustavo de Alencastro,Andrés F. Muro,Katja Pekrun,Mark A. Kay	14
6	Selection of rAAV vectors that cross the human blood-brain barrier and target the central nervous system using a transwell model 2022 ·Molecular Therapy — Methods & Clinical Development ·Song Ren,Katja Pekrun,Themasap A. Khan,Feijie Zhang,Sergiu P. Pașca,Mark A. Kay	25
7	Novel NanoLuc substrates enable bright two-population bioluminescence imaging in animals 2020 ·Nature Methods ·Yichi Su,Joel R. Walker,Yun‐Hee Park,Thomas P. Smith,(unknown),Mary P. Hall,Louai Labanieh,Robin Hurst,David C. Wang,Lance P. Encell,Namdoo Kim,Feijie Zhang,Mark A. Kay,Kerriann M. Casey,Robbie G. Majzner,Jennifer R. Cochran,Crystal L. Mackall,Thomas A. Kirkland,Michael Z. Lin	128
8	Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity 2017 ·Molecular Therapy ·Nicole K. Paulk,Katja Pekrun,Erhua Zhu,Sean Nygaard,(unknown),Jianpeng Xu,Kirk Chu,(unknown),(unknown),Annelise Haft,Yue Zhang,Feijie Zhang,(unknown),(unknown),(unknown),Amit C. Nathwani,(unknown),Markus Grompe,Ian E. Alexander,Leszek Lisowski,Mark A. Kay	139
9	A transfer-RNA-derived small RNA regulates ribosome biogenesisbreakdown → 2017 ·Nature ·Hak Kyun Kim,Gabriele Fuchs,Shengchun Wang,Wei Wei,Yue Zhang,(unknown),Biswajoy Roy‐Chaudhuri,Pan Li,Jianpeng Xu,Kirk Chu,Feijie Zhang,Mei‐Sze Chua,Samuel So,Qiangfeng Cliff Zhang,Peter Sarnow,Mark A. Kay	405
10	Sequence-Modified Antibiotic Resistance Genes Provide Sustained Plasmid-Mediated Transgene Expression in Mammals 2017 ·Molecular Therapy ·Jiamiao Lu,Feijie Zhang,Andrew Fire,Mark A. Kay	12
11	A 5′ Noncoding Exon Containing Engineered Intron Enhances Transgene Expression from Recombinant AAV Vectors in vivo 2016 ·Human Gene Therapy ·Jiamiao Lu,James A. Williams,Jeremy Luke,Feijie Zhang,Kirk Chu,Mark A. Kay	20
12	RNA interference–induced hepatotoxicity results from loss of the first synthesized isoform of microRNA-122 in mice 2016 ·Nature Medicine ·Paul N. Valdmanis,Shuo Gu,Kirk Chu,Lan Jin,Feijie Zhang,Elizabeth M. Munding,Yue Zhang,Yong Huang,Huban Kutay,Kalpana Ghoshal,Leszek Lisowski,Mark A. Kay	27
13	A Mini-intronic Plasmid (MIP): A Novel Robust Transgene Expression Vector In Vivo and In Vitro 2013 ·Molecular Therapy ·Jiamiao Lu,Feijie Zhang,Mark A. Kay	50
14	The Loop Position of shRNAs and Pre-miRNAs Is Critical for the Accuracy of Dicer Processing In Vivo 2012 ·Cell ·Shuo Gu,Lan Jin,Yue Zhang,Yong Huang,Feijie Zhang,Paul N. Valdmanis,Mark A. Kay	237
15	The Extragenic Spacer Length Between the 5′ and 3′ Ends of the Transgene Expression Cassette Affects Transgene Silencing From Plasmid-based Vectors 2012 ·Molecular Therapy ·Jiamiao Lu,Feijie Zhang,Siqun Xu,Andrew Fire,Mark A. Kay	57
16	Biological basis for restriction of microRNA targets to the 3′ untranslated region in mammalian mRNAs 2009 ·Nature Structural & Molecular Biology ·Shuo Gu,Lan Jin,Feijie Zhang,Peter Sarnow,Mark A. Kay	358
17	Mechanical ventilation with 40% oxygen reduces pulmonary expression of genes that regulate lung development and impairs alveolar septation in newborn mice 2007 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Richard D. Bland,Lucia M. Mokres,Robert Ertsey,(unknown),(unknown),Marlene Rabinovitch,Liwen Xu,Eric S. Shinwell,Feijie Zhang,(unknown)	60
18	Diesel Exhaust Particle-Exposed Human Bronchial Epithelial Cells Induce Dendritic Cell Maturation and Polarization via Thymic Stromal Lymphopoietin 2007 ·Journal of Clinical Immunology ·Bertram Bleck,Doris B. Tse,Maria A. Curotto de Lafaille,Feijie Zhang,Joan Reibman	94
19	Transforming Growth Factor–β Antagonizes Alveolar Type II Cell Proliferation Induced by Keratinocyte Growth Factor 2004 ·American Journal of Respiratory Cell and Molecular Biology ·Feijie Zhang,Larry D. Nielsen,Joseph J. Lucas,Robert J. Mason	50
20	Lipogenesis in Fetal Rat Lung 2003 ·American Journal of Respiratory Cell and Molecular Biology ·Feijie Zhang,Tianli Pan,Larry D. Nielsen,Robert J. Mason	41

About Feijie Zhang

Feijie Zhang is a scholar working on Genetics, Molecular Biology and Cancer Research, having authored 33 papers that have together received 2.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (12 papers), RNA Interference and Gene Delivery (12 papers) and CRISPR and Genetic Engineering (11 papers). The work is most often cited by research in Cancer Research (779 citations), Molecular Biology (1.7k citations) and Genetics (417 citations). Feijie Zhang has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Mark A. Kay, Shuo Gu, Lan Jin, Peter Sarnow, Yong Huang, Yue Zhang, Kirk Chu, Jianpeng Xu, Paul N. Valdmanis and Jiamiao Lu. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact